ACLXConference•businesswire•
Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference
Sentiment:Negative (15)
Summary
(NASDAQ:ACLX) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the 2025 Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2025 at 1:05 p.m. ET. A live webcast of this discussion will be accessible from Arcellx's website at www.arcellx.com in
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 3, 2025 by businesswire